Almost all the world's top 50 biopharmaceutical companies, including some of the most innovative R&D organizations developing groundbreaking therapies in fields such as cancer immunology, cell & gene therapy and vaccines, license at least one component of the Genedata Biopharma Platform. The company is headquartered in Basel, Switzerland with subsidiaries and offices in Germany, the United Kingdom, the United States, Singapore, and Japan.
